Sanofi India, Emcure Pharma announce exclusive distribution partnership

Sanofi India and Emcure Pharmaceuticals signed an exclusive distribution and promotion agreement, effective immediately.

Emcure Pharma will exclusively distribute and promote the Sanofi India’s cardiovascular (CV) range of products that include brands like Cardace, Clexane, Targocid, Lasix and Lasilactone.

Sanofi India will continue to own, import, and manufacture these brands across Sanofi’s plants in India and internationally, Emcure will engage healthcare professionals and expand reach of these therapeutic solutions across all areas of India.

Sanofi India’s concerned employees will have the opportunity to work at Emcure.